BACKGROUND The positive effects of growth hormone (GH) on IVF are often attributed to
improvements in oocyte and embryo quality. While emerging evidence emphasizes GH …

BACKGROUND There is a wealth of information regarding interventions for treating
subfertility. The majority of studies exploring interventions for improving conception rates …

Background Assisted reproductive technology (ART) has brought good news to infertile
patients, but how to improve the pregnancy outcome of poor ovarian response (POR) …

Growth hormone (GH) has been used as a co-gonadotrophin in assisted reproduction,
particularly in poor ovarian responders. The application of GH has been alleged to activate …

Growth hormone (GH) is mainly secreted by eosinophils of anterior pituitary gland. GH plays
an important role in regulating the growth and development of many tissues and cells, so it is …

Objective To investigate whether the depot gonadotropin‐releasing hormone (GnRH)
agonist protocol could improve in vitro fertilization (IVF) outcomes for young poor responders …

Growth hormone, letrozole, and clomiphene citrate do not have US Food and Drug
Administration approval for their use in in vitro fertilization (IVF) cycles. However, despite this …

Objective To appraise the current randomized clinical trials (RCTs) for evidence of the
association of growth hormone (GH) with improved outcomes in infertile women with …

Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …

Purpose This study aimed to evaluate the impact of luteal phase ovarian stimulation (LPS)
on the outcomes of assisted reproductive technology (ART) for infertile couples and patients …